| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |